.

Flexible Flat-Rate Plans

Flat-rate pricing for predictable budgeting

Short-term plans for project- or client-based billing

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Sanofi Aventis Us Company Profile

« Back to Dashboard

Summary for Applicant: Sanofi Aventis Us

Patents:59
Tradenames:113
Ingredients:93
NDAs:136
Drug Master File Entries: (click here to view)135
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sanofi Aventis Us
PRIMAQUINE
primaquine phosphate
TABLET;ORAL008316-001Approved Prior to Jan 1, 1982RXYes<disabled><disabled>
Sanofi Aventis Us
ALLEGRA-D 24 HOUR ALLERGY AND CONGESTION
fexofenadine hydrochloride; pseudoephedrine hydrochloride
TABLET, EXTENDED RELEASE;ORAL021704-002Jan 24, 2011OTCYes6,613,357<disabled>Y <disabled>
Sanofi Aventis Us
PRIMACOR
milrinone lactate
INJECTABLE;INJECTION019436-001Dec 31, 1987DISCNNo<disabled><disabled>
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

`abc